bit.bio

bit.bio is a Cambridge-based synthetic biology company that programmes human induced pluripotent stem cells into defined, mature cell types for use in pharmaceutical and academic research.

Its precision cell programming technology produces consistent, characterised human cells at industrial scale, supporting drug discovery, disease modelling, and safety testing across neurological, hepatic, and metabolic research areas.

The company maintains a cell therapy development programme and is expanding into toxicology testing.